BNP Paribas Exane Upgrades Adient (ADNT) to Outperform

BNP Paribas Exane analyst James Picariello upgraded Adient (NYSE: ADNT) from Neutral to Outperform with a price target of $26.00.

For an analyst ratings summary and ratings history on Adient click here. For more ratings news on Adient click here.

Shares of Adient closed at $21.58 yesterday.

You May Also Be Interested In

• Goldman Sachs Upgrades Mineral Resources Limited (MIN:AU) (MALRF) to Neutral
• Nomura/Instinet Upgrades Hyundai Heavy Industries (329180:KS) to Buy
• New Street Research Upgrades Arm Holdings (ARM) to Buy